Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Hamidreza Safari, Gholamreza Anani Sarab & Mohsen Naseri. (2021)
Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model. Nutritional Neuroscience 24:11, pages 843-849.
Read now
Read now
Robin Boltjes, Stephanie Knippenberg, Oliver Gerlach, Raymond Hupperts & Jan Damoiseaux. (2021) Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence. Expert Review of Neurotherapeutics 21:6, pages 715-725.
Read now
Read now
Krystal Iacopetta, Lyndsey E. Collins-Praino, Femke T. A. Buisman-Pijlman, Jiajun Liu, Amanda D. Hutchinson & Mark R. Hutchinson. (2020) Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review. Nutritional Neuroscience 23:4, pages 251-280.
Read now
Read now
Kate Rittenhouse-Olson. (2019) Thematic 2019 Letter from the Editor. Immunological Investigations 48:7, pages 673-679.
Read now
Read now
. (2018) Thematic 2018 Letter from the Editor. Immunological Investigations 47:8, pages 765-769.
Read now
Read now
Kate Rittenhouse-Olson. (2018) Letter from the Editor June 2018. Immunological Investigations 47:6, pages 543-546.
Read now
Read now
Shiva Khezri, Seyyed Meysam Abtahi Froushani & Mozhgan Shahmoradi. (2018) Nicotine Augments the Beneficial Effects of Mesenchymal Stem Cell-based Therapy in Rat Model of Multiple Sclerosis. Immunological Investigations 47:2, pages 113-124.
Read now
Read now
Edgard Delvin, Jean-Claude Souberbielle, Jean-Paul Viard & Bernard Salle. (2014) Role of vitamin D in acquired immune and autoimmune diseases. Critical Reviews in Clinical Laboratory Sciences 51:4, pages 232-247.
Read now
Read now
Georgia Kassi, Konstantinos Papamichael, Garyfallia Papaioannou, Irene Giagourta, Stavroula Thanou, Maria Triantaphyllopoulou, Evagelia Zapanti, Fotini Papandroulaki, Vasiliki Ktena & Helen Karga. (2014) Cytokines and Insulin Resistance after Zoledronic Acid-Induced Acute Phase Response. Immunological Investigations 43:6, pages 544-555.
Read now
Read now
Seyyed Meysam Abtahi Froushani, Norouz Delirezh, Rahim Hobbenaghi & Ghasem Mosayebi. (2014) Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunological Investigations 43:1, pages 54-68.
Read now
Read now
Jonatan Salzer, Martin Biström & Peter Sundström. (2014) Vitamin D and multiple sclerosis: where do we go from here?. Expert Review of Neurotherapeutics 14:1, pages 9-18.
Read now
Read now
Trygve Holmøy, Margitta T Kampman & Joost Smolders. (2012) Vitamin D in multiple sclerosis: implications for assessment and treatment. Expert Review of Neurotherapeutics 12:9, pages 1101-1112.
Read now
Read now
Articles from other publishers (88)
Kassandra L. Munger & Alberto Ascherio. 2024. Feldman and Pike's Vitamin D. Feldman and Pike's Vitamin D
1167
1184
.
Eryn Bugbee, Angela A. Wang & Jennifer L. Gommerman. (2023) Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis. Frontiers in Immunology 14.
Crossref
Crossref
Shorouk Hajeer, Farah Nasr, Sanaa Nabha, Marie-belle Saab, Hayat Harati, Alban Desoutter, Elie Al Ahmar & Elias Estephan. (2023) Association between vitamin D deficiency and multiple sclerosis- MRI significance: A scoping review. Heliyon 9:5, pages e15754.
Crossref
Crossref
Julie Langlois & Damien Denimal. (2023) Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review. Nutrients 15:8, pages 1945.
Crossref
Crossref
Weronika Galus, Tomasz Chmiela, Anna Walawska-Hrycek & Ewa Krzystanek. (2023) Radiological Benefits of Vitamin D Status and Supplementation in Patients with MS—A Two-Year Prospective Observational Cohort Study. Nutrients 15:6, pages 1465.
Crossref
Crossref
Weixia Wang, Yijin Li & Xianfang Meng. (2023) Vitamin D and neurodegenerative diseases. Heliyon 9:1, pages e12877.
Crossref
Crossref
Weronika Galus, Anna Walawska-Hrycek, Michalina Rzepka & Ewa Krzystanek. (2022) Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals. Journal of Clinical Medicine 11:24, pages 7278.
Crossref
Crossref
Dohyup Kim, Emily E. Witt, Simone Schubert, Elias Sotirchos, Pavan Bhargava, Ellen M. Mowry, Karen Sachs, Biter Bilen, Lawrence Steinman, Avni Awani, Zihuai He, Peter A. Calabresi & Keith Van Haren. (2022) Peripheral T-Cells, B-Cells, and Monocytes from Multiple Sclerosis Patients Supplemented with High-Dose Vitamin D Show Distinct Changes in Gene Expression Profiles. Nutrients 14:22, pages 4737.
Crossref
Crossref
Manon Galoppin, Saniya Kari, Sasha Soldati, Arindam Pal, Manon Rival, Britta Engelhardt, Anne Astier & Eric Thouvenot. (2022) Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Communications 4:4.
Crossref
Crossref
Zeinab Ghorbani, Pegah Rafiee, Samaneh Haghighi, Soodeh Razeghi Jahromi, Mahmoud Djalali, Hedieh Moradi-Tabriz, Maryam Mahmoudi & Mansoureh Togha. (2021) The effects of vitamin D3 supplementation on TGF-β and IL-17 serum levels in migraineurs: post hoc analysis of a randomized clinical trial. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Cristina Fernandez-Carbonell, Leigh E. Charvet & Lauren B. Krupp. (2021) Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis. Pediatric Drugs 23:4, pages 317-329.
Crossref
Crossref
Wakunyambo Maboshe, Helen M. Macdonald, Heather Wassall, William D. Fraser, Jonathan C. Y. Tang, Shona Fielding, Robert N. Barker, Mark A. Vickers, Anthony Ormerod & Frank Thies. (2021) Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial. Frontiers in Immunology 12.
Crossref
Crossref
Anna Walawska-Hrycek, Weronika Galus, Eugeniusz Hrycek, Aleksandra Kaczmarczyk & Ewa Krzystanek. (2021) The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients. Journal of Clinical Medicine 10:13, pages 2781.
Crossref
Crossref
Shima Mehrabadi & Elham Zahedi. (2021) Effects of Vitamin D Supplementation on Inflammatory Markers in Multiple Sclerosis Patients: A Systematic Review and Meta-analysis. Journal of Archives in Military Medicine 9:1.
Crossref
Crossref
Justin R. Abbatemarco, Robert J. Fox, Hong Li, Robert A. Bermel & Daniel Ontaneda. (2021) Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis. International Journal of MS Care 23:2, pages 53-58.
Crossref
Crossref
Sara Hanaei, MohammadAli Sahraian, Mehdi Mohammadifar, SreeramV Ramagopalan & Mahsa Ghajarzadeh. (2021) Effect of Vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): A systematic review and meta-analysis. International Journal of Preventive Medicine 12:1, pages 42.
Crossref
Crossref
Xiaofan Yuan, Lei Guo, Chuan Jiang, Xu Yang & Jie Huang. (2021) The Effect of Different Administration Time and Dosage of Vitamin D Supplementation in Patients with Multiple Sclerosis: A Meta-Analysis of Randomized Controlled Trials. Neuroimmunomodulation 28:3, pages 118-128.
Crossref
Crossref
Wei Zhen Yeh, Melissa Gresle, Vilija Jokubaitis, Jim Stankovich, Anneke Walt & Helmut Butzkueven. (2020) Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis. British Journal of Pharmacology 177:18, pages 4113-4133.
Crossref
Crossref
Yifan Wu, Yu Cai, Mingyuan Liu, Desheng Zhu & Yangtai Guan. (2020) The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis and Related Disorders 43, pages 102156.
Crossref
Crossref
Samiksha Wasnik, Isha Sharma, David J. Baylink & Xiaolei Tang. (2020) Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?. International Journal of Molecular Sciences 21:9, pages 3102.
Crossref
Crossref
Julia Feige, Tobias Moser, Lara Bieler, Kerstin Schwenker, Larissa Hauer & Johann Sellner. (2020) Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats. Nutrients 12:3, pages 783.
Crossref
Crossref
Inga Wessels & Lothar Rink. (2020) Micronutrients in autoimmune diseases: possible therapeutic benefits of zinc and vitamin D. The Journal of Nutritional Biochemistry 77, pages 108240.
Crossref
Crossref
Priscilla Bäcker-Koduah, Judith Bellmann-Strobl, Michael Scheel, Jens Wuerfel, Klaus-Dieter Wernecke, Jan Dörr, Alexander Ulrich Brandt & Friedemann Paul. (2020) Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS). Frontiers in Neurology 11.
Crossref
Crossref
Michael J. Bradshaw, Michael F. Holick & James M. Stankiewicz. 2020. Clinical Neuroimmunology. Clinical Neuroimmunology
197
212
.
Amin Doosti-Irani, Omid Reza Tamtaji, Mohammad Ali Mansournia, Majid Ghayour- Mobarhan, Gordon Ferns, Reza Daneshvar Kakhaki, Arash Rezaei Shahmirzadi & Zatollah Asemi. (2019) The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials. Clinical Neurology and Neurosurgery 187, pages 105564.
Crossref
Crossref
Justin R. Abbatemarco, Robert J. Fox, Hong Li & Daniel Ontaneda. (2019) Vitamin D and MRI measures in progressive multiple sclerosis. Multiple Sclerosis and Related Disorders 35, pages 276-282.
Crossref
Crossref
William CamuPhilippe LehertCharles Pierrot-DeseillignyPatrick HautecoeurAnne BesserveAnne-Sophie Jean DelegliseMarianne PayetEric Thouvenot & Jean Claude Souberbielle. (2019) Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE). Neurology Neuroimmunology & Neuroinflammation 6:5.
Crossref
Crossref
Fardin Faraji, Mahya Hashemi, Atefeh Ghiasabadi, Sadaf Davoudian, Afsoon Talaie, Ali Ganji & Ghasem Mosayebi. (2019) Combination therapy with interferon beta-1a and sesame oil in multiple sclerosis. Complementary Therapies in Medicine 45, pages 275-279.
Crossref
Crossref
Monika Berezowska, Shelly Coe & Helen Dawes. (2019) Effectiveness of Vitamin D Supplementation in the Management of Multiple Sclerosis: A Systematic Review. International Journal of Molecular Sciences 20:6, pages 1301.
Crossref
Crossref
Merat Mahmoodi, Fatemeh Ayoobi, Azita Aghaei, Mehdi Rahmani, Zahra Taghipour, Azar Hosseini, Abdollah Jafarzadeh & Mojtaba Sankian. (2019) Beneficial effects of Thymus vulgaris extract in experimental autoimmune encephalomyelitis: Clinical, histological and cytokine alterations. Biomedicine & Pharmacotherapy 109, pages 2100-2108.
Crossref
Crossref
Mir Hojjat Khorasanizadeh, Mahsa Eskian, Carlos A. CamargoJr.Jr. & Nima Rezaei. 2019. Nutrition and Immunity. Nutrition and Immunity
15
51
.
Mark J. Bolland, Andrew Grey & Alison Avenell. (2018) Assessment of research waste part 2: wrong study populations- an exemplar of baseline vitamin D status of participants in trials of vitamin D supplementation. BMC Medical Research Methodology 18:1.
Crossref
Crossref
Vanitha A Jagannath, Graziella Filippini, Israel Junior Borges do Nascimento, Carlo Di Pietrantonj, Edward W Robak & Liz Whamond. (2018) Vitamin D for the management of multiple sclerosis. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Chao Zheng, Liang He, Lingling Liu, Jie Zhu & Tao Jin. (2018) The efficacy of vitamin D in multiple sclerosis: A meta-analysis. Multiple Sclerosis and Related Disorders 23, pages 56-61.
Crossref
Crossref
Andreia Bettencourt, Daniela Boleixa, Henrique Reguengo, Raquel Samões, Ernestina Santos, José Carlos Oliveira, Berta Silva, Paulo Pinho Costa & Ana Martins da Silva. (2018) Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal. The Journal of Steroid Biochemistry and Molecular Biology 180, pages 137-141.
Crossref
Crossref
Martina B. Sintzel, Mark Rametta & Anthony T. Reder. (2017) Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurology and Therapy 7:1, pages 59-85.
Crossref
Crossref
Meenakshi Umar, Konduru Sastry & Aouatef Chouchane. (2018) Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies. International Journal of Molecular Sciences 19:6, pages 1618.
Crossref
Crossref
Maria Pia Amato, Tobias Derfuss, Bernard Hemmer, Roland Liblau, Xavier Montalban, Per Soelberg Sørensen, David H MillerLars Alfredsson, Francesca Aloisi, Maria Pia Amato, Alberto Ascherio, Elisa Baldin, Kjetil Bjørnevik, Manuel Comabella, Jorge Correale, Marianna Cortese, Tobias Derfuss, Marie D’Hooghe, Angelo Ghezzi, Julian Gold, Kerstin Hellwig, Bernhard Hemmer, Nils Koch-Henricksen, Annette Langer Gould, Roland Liblau, Ralf Linker, Francesco Lolli, Robyn Lucas, Jan Lünemann, Melinda Magyari, Luca Massacesi, Ariel Miller, David H Miller, Xavier Montalban, Philippe Monteyne, Ellen Mowry, Christian Münz, Nete M Nielsen, Tomas Olsson, Celia Oreja-Guevara, Susana Otero, Maura Pugliatti, Stephen Reingold, Trond Riise, Neil Robertson, Marco Salvetti, Youssef Sidhom, Joost Smolders, Per Soelberg Sørensen, Ludvig Sollid, Israel Steiner, Egon Stenager, Peter Sundstrom, Bruce V Taylor, Helen Tremlett, Maria Trojano, Antonio Uccelli, Emmanuelle Waubant & Hartmut Wekerle. (2017) Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. Multiple Sclerosis Journal 24:5, pages 590-603.
Crossref
Crossref
Ming Lu, Bruce V. Taylor & Heinrich Körner. (2018) Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis. Frontiers in Immunology 9.
Crossref
Crossref
Ellen M. Mowry & Justin D. Glenn. (2018) The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease. Neurologic Clinics 36:1, pages 185-196.
Crossref
Crossref
Sunčica Stankov & Bogdan Stepančev. (2018) Vitamin D role in multiple sclerosis etiology and therapy. Medicinski casopis 52:1, pages 15-21.
Crossref
Crossref
Suzi B Claflin, Ingrid A F van der Mei & Bruce V Taylor. (2018) Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016. Journal of Neurology, Neurosurgery & Psychiatry 89:1, pages 34-41.
Crossref
Crossref
Shima Tavakol, Sahar Shakibapour & Sepideh Arbabi Bidgoli. (2016) The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future. Molecular Neurobiology 55:1, pages 462-469.
Crossref
Crossref
Tarek Nafee, Rodrigo Watanabe & Felipe Fregni. 2018. Clinical Trials in Neurology. Clinical Trials in Neurology
263
295
.
Zarintaj Malihi, Zhenqiang Wu, Carlene MM Lawes & Robert Scragg. (2017) Noncalcemic adverse effects and withdrawals in randomized controlled trials of long-term vitamin D2 or D3 supplementation: a systematic review and meta-analysis. Nutrition Reviews 75:12, pages 1007-1034.
Crossref
Crossref
Francesco Colotta, Birger Jansson & Fabrizio Bonelli. (2017) Modulation of inflammatory and immune responses by vitamin D. Journal of Autoimmunity 85, pages 78-97.
Crossref
Crossref
An-Sofie Vanherwegen, Conny Gysemans & Chantal Mathieu. (2017) Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity. Endocrinology and Metabolism Clinics of North America 46:4, pages 1061-1094.
Crossref
Crossref
Abdulla Watad, Shir Azrielant, Nicola Luigi Bragazzi, Kassem Sharif, Paula David, Itay Katz, Gali Aljadeff, Mariana Quaresma, Galya Tanay, Mohammad Adawi, Howard Amital & Yehuda Shoenfeld. (2017) Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity. Journal of Autoimmunity 82, pages 13-30.
Crossref
Crossref
May F. Mrad, Nabil K. El Ayoubi, Maria O. Esmerian, Jalal M. Kazan & Samia J. Khoury. (2017) Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis. Clinical Immunology 181, pages 9-15.
Crossref
Crossref
Charles Pierrot-Deseilligny & Jean-Claude Souberbielle. (2017) Vitamin D and multiple sclerosis: An update. Multiple Sclerosis and Related Disorders 14, pages 35-45.
Crossref
Crossref
Wen‑Juan Huang, Wei‑Wei Chen & Xia Zhang. (2017) Multiple sclerosis: Pathology, diagnosis and treatments (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Wendy Dankers, Edgar M. Colin, Jan Piet van Hamburg & Erik Lubberts. (2017) Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Frontiers in Immunology 7.
Crossref
Crossref
C.E. Hayes & J.A. Spanier. 2017. Nutrition and Lifestyle in Neurological Autoimmune Diseases. Nutrition and Lifestyle in Neurological Autoimmune Diseases
81
107
.
M. Niino & Y. Miyazaki. 2017. Nutrition and Lifestyle in Neurological Autoimmune Diseases. Nutrition and Lifestyle in Neurological Autoimmune Diseases
71
80
.
Vikram Bhise, Konstantin Balashov, Marc Sturgill, Lauren Krupp & Suhayl Dhib-Jalbut. (2016) Cytokine profiles in pediatric multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders 1:1.
Crossref
Crossref
Anne-Hilde Muris, Joost Smolders, Linda Rolf, Marielle Thewissen, Raymond Hupperts & Jan Damoiseaux. (2016) Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study. Journal of Neuroimmunology 300, pages 47-56.
Crossref
Crossref
W Brola, P Sobolewski, W Szczuchniak, A Góral, M Fudala, W Przybylski & J Opara. (2016) Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. European Journal of Clinical Nutrition 70:9, pages 995-999.
Crossref
Crossref
Claire McCarthy & John Thorpe. (2016) Some recent advances in multiple sclerosis. Journal of Neurology 263:9, pages 1880-1886.
Crossref
Crossref
L.A.N. Mimura, F. Chiuso-Minicucci, T.F.C. Fraga-Silva, S.F.G. Zorzella-Pezavento, T.G.D. França, L.L.W. Ishikawa, M. Penitenti, M.R.V. Ikoma & A. Sartori. (2016) Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development. Neuroscience 317, pages 130-140.
Crossref
Crossref
Pang Yao, Ling Lu, Yao Hu, Gang Liu, Xiafei Chen, Liang Sun, Xingwang Ye, He Zheng, Yan Chen, Frank B. Hu, Huaixing Li & Xu Lin. (2015) A dose–response study of vitamin D3 supplementation in healthy Chinese: a 5-arm randomized, placebo-controlled trial. European Journal of Nutrition 55:1, pages 383-392.
Crossref
Crossref
P.S. Sorensen, K. Schreiber & A.K. Andreasen. 2016. Translational Neuroimmunology in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis
347
364
.
Anusha K. Yeshokumar, Deanna Saylor, Michael D. Kornberg & Ellen M. Mowry. (2015) Evidence for the Importance of Vitamin D Status in Neurologic Conditions. Current Treatment Options in Neurology 17:12.
Crossref
Crossref
Egil R?sj?Linn H. Steffensen, Lone J?rgensen, Jonas C. Lindstr?m, J?rat? ?altyt? Benth, Annika E. Michelsen, P?l Aukrust, Thor Ueland, Margitta T. Kampman, ?ivind Torkildsen & Trygve Holm?y. (2015) Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. Journal of Neurology 262:12, pages 2713-2721.
Crossref
Crossref
Zeinab Shirvani-Farsani, Mehrdad Behmanesh, Seyed Mahdi Mohammadi & Abdorreza Naser Moghadasi. (2015) Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression. Life Sciences 134, pages 63-67.
Crossref
Crossref
Gorm Pihl-Jensen & Jette Lautrup Frederiksen. (2015) 25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. Journal of Neurology 262:7, pages 1646-1654.
Crossref
Crossref
Masaaki NiinoYusei Miyazaki. (2015) Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis. Canadian Journal of Physiology and Pharmacology 93:5, pages 319-325.
Crossref
Crossref
Katja Schmitz, Julia Barthelmes, Leonie Stolz, Susanne Beyer, Olaf Diehl & Irmgard Tegeder. (2015) “Disease modifying nutricals” for multiple sclerosis. Pharmacology & Therapeutics 148, pages 85-113.
Crossref
Crossref
Zeinab Shirvani Farsani, Mehrdad Behmanesh & Mohammad Ali Sahraian. (2015) Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients. Journal of the Neurological Sciences 350:1-2, pages 18-23.
Crossref
Crossref
Zhong-Xiang Xie, Hong-Liang Zhang, Xiu-Juan Wu, Jie Zhu, Di-Hui Ma & Tao Jin. (2015) Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis. Mediators of Inflammation 2015, pages 1-20.
Crossref
Crossref
G. Pioggia, A. Tonacci, G. Tartarisco, L. Billeci, F. Muratori, L. Ruta & S. Gangemi. (2014) Autism and lack of D3 vitamin: A systematic review. Research in Autism Spectrum Disorders 8:12, pages 1685-1698.
Crossref
Crossref
S. Kimball, H.E. Hanwell, J.M. Burton, R.P. Heaney, M.F. Holick, B. Hollis, R. Lewanczuk, N. Makhani & S. Venkateswaran. (2014) Vitamin D supplementation in multiple sclerosis: Making a case for clarity. Journal of the Neurological Sciences 347:1-2, pages 391-392.
Crossref
Crossref
Aravind Ganesh, Sabrina Apel, Luanne Metz & Scott Patten. (2013) The case for vitamin D supplementation in multiple sclerosis. Multiple Sclerosis and Related Disorders 2:4, pages 281-306.
Crossref
Crossref
Roopali Gandhi, Brian Healy, Taha Gholipour, Svetlana Egorova, Alexander Musallam, Mohammad Shuja Hussain, Parham Nejad, Bonny Patel, Hillary Hei, Samia Khoury, Francisco Quintana, Pia Kivisakk, Tanuja Chitnis & Howard L. Weiner. (2013) Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis. Annals of Neurology 73:6, pages 729-740.
Crossref
Crossref
Mark S. Freedman, Daniel Selchen, Douglas L. Arnold, Alexandre Prat, Brenda Banwell, Michael Yeung, David Morgenthau & Yves Lapierre. (2014) Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:3, pages 307-323.
Crossref
Crossref
Sarah Hewer, Robyn Lucas, Ingrid van der Mei & Bruce V. Taylor. (2013) Vitamin D and multiple sclerosis. Journal of Clinical Neuroscience 20:5, pages 634-641.
Crossref
Crossref
Jean Fletcher, Michael Hutchinson & Niall Tubridy. (2012) Response to comment on the article by Allen et al. ‘A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers’. Multiple Sclerosis Journal 19:4, pages 509-509.
Crossref
Crossref
Anne-Hilde Muris, Joost Smolders & Jan Damoiseaux. (2012) Comment on the article by Allen et al. ‘A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers’. Multiple Sclerosis Journal 19:4, pages 510-510.
Crossref
Crossref
Charles Pierrot-Deseilligny & Jean-Claude Souberbielle. (2013) Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Therapeutic Advances in Neurological Disorders 6:2, pages 81-116.
Crossref
Crossref
A. D?ring, F. Paul & J. D?rr. (2012) Vitamin?D und Multiple SkleroseVitamin?D and multiple sclerosis. Der Nervenarzt 84:2, pages 173-189.
Crossref
Crossref
Sandra Mesliniene, Laurie Ramrattan, Stanley Giddings & Mae Sheikh-Ali. (2013) Role of Vitamin D in the Onset, Progression, and Severity of Multiple Sclerosis. Endocrine Practice 19:1, pages 129-136.
Crossref
Crossref
Beatriz Pozuelo-Moyano, Juli?n Benito-Le?n, Alex J. Mitchell & Jes?s Hern?ndez-Gallego. (2013) A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis. Neuroepidemiology 40:3, pages 147-153.
Crossref
Crossref
T. Holm?y, ?. Torkildsen, K.-M. Myhr & K. I. L?ken-Amsrud. (2012) Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. Acta Neurologica Scandinavica 126, pages 63-69.
Crossref
Crossref
Alireza Faridar, Ghazaleh Eskandari, Mohammad Ali Sahraian, Alireza Minagar & Amirreza Azimi. (2012) Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurologica Belgica 112:4, pages 327-333.
Crossref
Crossref
Barbara M. van Amerongen & François Feron. (2012) Effect of High-Dose Vitamin D3 Intake on Ambulation, Muscular Pain and Bone Mineral Density in a Woman with Multiple Sclerosis: A 10-Year Longitudinal Case Report. International Journal of Molecular Sciences 13:12, pages 13461-13483.
Crossref
Crossref
Margitta T Kampman, Linn H Steffensen, Svein I Mellgren & Lone Jørgensen. (2012)
Effect of vitamin D
3
supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
. Multiple Sclerosis Journal 18:8, pages 1144-1151.
Crossref
Crossref
Sandhya Subramanian, Lisa M. Miller, Marjorie R. Grafe, Arthur A. Vandenbark & Halina Offner. (2011) Contribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE. Metabolic Brain Disease 27:1, pages 29-35.
Crossref
Crossref
Ingrid AF van der Mei, Steve Simpson, Stephanie Knippenberg, Tania Winzenberg & Bruce V Taylor. (2011) Role of vitamin D in multiple sclerosis: implications for disease management. Neurodegenerative Disease Management 1:6, pages 523-536.
Crossref
Crossref
Kassandra L Munger & Alberto Ascherio. (2011) Prevention and treatment of MS: studying the effects of vitamin D. Multiple Sclerosis Journal 17:12, pages 1405-1411.
Crossref
Crossref